Country: United States
Language: English
Source: NLM (National Library of Medicine)
HEPARIN SODIUM (UNII: ZZ45AB24CA) (HEPARIN - UNII:T2410KM04A)
Cardinal Health
HEPARIN SODIUM
HEPARIN 5000 [USP'U] in 1 mL
PRESCRIPTION DRUG
New Drug Application
HEPARIN SODIUM- HEPARIN SODIUM INJECTION CARDINAL HEALTH ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE HEPARIN SODIUM INJECTION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR HEPARIN SODIUM INJECTION. HEPARIN SODIUM INJECTION, FOR INTRAVENOUS OR SUBCUTANEOUS USE INITIAL U.S. APPROVAL: 1939 INDICATIONS AND USAGE HEPARIN SODIUM INJECTION is an anticoagulant indicated for (1): • • • • • • DOSAGE AND ADMINISTRATION Recommended Adult Dosages: * • Deep Subcutaneous (Intrafat) Injection _Use a different site for each_ _injection_ Initial Dose 333 units/kg subcutaneously Every 12 hours 250 units/kg subcutaneously Inte rmitte nt IV Injection Initial Dose 10,000 units Every 4 to 6 hours 5,000 to 10,000 units Continuous IV Infusion Initial Dose 5,000 units Continuous 20,000 to 40,000 units/24 hours • Intravascular via Total Body Perfusion Initial Dose ≥150 units/kg; adjust for longer proce dure s • Deep Subcutaneous (Intrafat) Injection Initial Dose 5,000 units 2 hours before surgery Every 8 to 12 hours 5,000 units • Intravascular via Extracorporeal Dialysis 25 to 30 units/kg followed by infusion rate of 1,500 to 2,000 units/hour if manufacturers' recommendations are not available DOSAGE FORMS AND STRENGTHS PRE SE RVATIVE -FRE E PRESERVED WITH BENZYL ALCOHOL 1,000 USP units/mL 1,000 USP units/mL Prophylaxis and treatment of venous thromboembolism Prophylaxis and treatment of the thromboembolic complications associated with atrial fibrillation Treatment of acute and chronic consumption coagulopathies Prevention of clotting in arterial and cardiac surgery Prophylaxis and treatment of peripheral arterial embolism Anticoagulant use in transfusion, extracorporeal circulation, and dialysis procedures Based on 150 lb. (68 kg) patient. Adjust dose based on laboratory monitoring. Therapeutic Anticoagulant Effect with Full-Dose Heparin (2.3) * Cardiovascular Surgery (2.5) Low-dose Prophylaxis of Postoperative Thromboembolism (2.6) Read the complete document